References
- Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000;292:1–8
- Ishida Y, Abe Y, Harabuchi Y. Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes. Int J Pediatr Otorhinolaringol 2007;71(2):297–305
- Terao H, Asano K, KanaI K, et al. Suppressive activity of macrolides antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm 2003;12: 195–202
- Miyazaky M, Zaitsu M, Honjo K, et al. Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003;69:229–35
- Inoue S, Nakase H, Matsuura M, et al. Open label trial of clarithromycin therapy in Japanese patients with Crohn’s disease. J Gastroenterol Hepatol 2007;22(7):984–8
- Saviola G, Abdi-Ali L, Cirino G, et al. Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. Clin Exp Rheumatol 2002;20:373–8
- Saviola G, Abdi-Ali L, Shams-Eddin S, et al. Clarithromycin in adult-onset Still’s disease. Case report with 1-year follow-up. Clin Exp Rheumatol, 2004;22: 379
- Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin 2007;23(3):515–22
- Rashid T, Darlington G, Kjeldsen-Kregh J, et al: Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol 1999;18(3):190–5
- Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Net Rev Immunol 2007;7(2):161–7
- Hernandez-Cruz B, Cardiel MH, Villa AR, et al. Developement, recurrence and severity of infections in Mexicans patients with rheumatoid arthritis. A nested case-control study. J Rheumatol 1998;25(10):1900–7
- Symmons DP. Mortality in rheumatoid arthritis. Br J Rheumatol 1998;27(Suppl 1):44–54
- Firestein GS, Panayi GS, Wollheim FA. Rheumatoid Arthritis. New Frontiers in Pathogenesis and Treatment, Oxford University Press, Oxford, UK, 2000
- van der Veen MJ, van der Heide A, Kruize AA, et al. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53(4):224
- Doran MF, Crowson CS, Pond GR, et al: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46(9):2287–93
- Moskowitz RW, Lesko M, Hooper M. Open-label study of clarithromycin in patients with undifferentiated connective tissue disease. Semin Arthritis Rheum 2006;36:82–7